Delivery Order SPE2DR25D9168-SPE2DR26FCRF2
- Not listed
- The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,373.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nuplazid 10 mg tablets (30-count packages). The award, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries a firm fixed-price contract type with no set-aside designation, indicating the vendor competed in unrestricted federal...
- The Defense Logistics Agency awarded a $21,177.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in quantities of 30. The delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for Nuplazid 34 mg capsules (30-count packaging) valued at $10,375.53. This firm fixed-price delivery order, which carries no set-aside designation, represents a specific fulfillment under the company's broader Indefinite Delivery Contract with DLA. The contract will be completed by November...
- The Defense Logistics Agency awarded a delivery order valued at $20,751.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUPLAZID 34 mg capsules (30-count packaging). This firm fixed-price delivery order, issued on October 23, 2025, with an ultimate completion date of November 14, 2025, carries no set-aside designation, indicating the award was made through open competition. The delivery order was...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The award, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, carries no set-aside designation. This delivery order represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency issued a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count packaging. This delivery order was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, utilizing firm fixed-price pricing with no set-aside designation. The order represents a discrete fulfillment under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count units. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units), with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued on September 15, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this work at its primary facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30. This firm fixed-price delivery order, which carries an ultimate completion date of September 3, 2025, represents a direct procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois, and supports the pharmaceutical supply needs of Department...
- SPE2DR25D9168Indefinite Delivery Contract
- SPE2DR25D9168-SPE2DR26FCRF2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,588.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count packages). The award, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, utilizes firm fixed-price pricing and does not include a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was recently awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents the Defense Logistics Agency's comprehensive pharmaceutical supply strategy, part of a broader $30.3 billion acquisition initiative designed to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's role as a regional prime vendor contractor enables the agency to issue delivery orders for a diverse portfolio of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables. The company's selection and demonstrated performance on numerous recent delivery orders reflect its capability to fulfill specialized pharmaceutical requirements across military healthcare facilities worldwide, with no subcontractor relationships identified in the award documentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 10/28/25 |